Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biosense Webster Touts Ablation Catheters’ Atrial Flutter Curative Properties

This article was originally published in The Gray Sheet

Executive Summary

Successful ablation using Biosense Webster's NaviStar DS and Celsius DS catheters can cure and eliminate atrial flutter arrhythmia in cases where available pharmaceutical treatments are only palliative, according to the firm

You may also be interested in...



Boston Scientific Enters U.S. Atrial Flutter Market With EPT-1000 XP

Boston Scientific aims to carve out a leading share of the estimated $50-$60 mil. worldwide atrial flutter market opportunity with the EPT-1000 XP cardiac ablation system, the firm says

Allowing States To Ban Abortion Services Increases Calls For Making Birth Control Available OTC

Supreme Court’s six conservative justices say Constitution doesn’t guarantee a woman’s right to abortion services nor prohibit states from regulating or banning the services. Dissenting liberal members decry decision as erasing women’s constitutional rights.

Latest News
UsernamePublicRestriction

Register

MT017393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel